Correlation Between Vanguard Small and Loncar Cancer

Can any of the company-specific risk be diversified away by investing in both Vanguard Small and Loncar Cancer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanguard Small and Loncar Cancer into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vanguard Small Cap Index and Loncar Cancer Immunotherapy, you can compare the effects of market volatilities on Vanguard Small and Loncar Cancer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanguard Small with a short position of Loncar Cancer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanguard Small and Loncar Cancer.

Diversification Opportunities for Vanguard Small and Loncar Cancer

0.63

Correlation Coefficient

Vanguard Small  Loncar Cancer

Poor diversification

The 3 months correlation between Vanguard and Loncar is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Vanguard Small Cap Index and Loncar Cancer Immunotherapy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Loncar Cancer Immuno and Vanguard Small is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanguard Small Cap Index are associated (or correlated) with Loncar Cancer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Loncar Cancer Immuno has no effect on the direction of Vanguard Small i.e., Vanguard Small and Loncar Cancer go up and down completely randomly.

Pair Corralation between Vanguard Small and Loncar Cancer

Allowing for the 90-day total investment horizon Vanguard Small Cap Index is expected to generate 0.45 times more return on investment than Loncar Cancer. However, Vanguard Small Cap Index is 2.25 times less risky than Loncar Cancer. It trades about 0.01 of its potential returns per unit of risk. Loncar Cancer Immunotherapy is currently generating about -0.03 per unit of risk. If you would invest  24,757  in Vanguard Small Cap Index on November 19, 2024 and sell it today you would earn a total of  38.00  from holding Vanguard Small Cap Index or generate 0.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Vanguard Small Cap Index  vs.  Loncar Cancer Immunotherapy

Vanguard Small Cap

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vanguard Small Cap Index has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, Vanguard Small is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Loncar Cancer Immuno

Risk-Adjusted Performance

Very Weak

Over the last 90 days Loncar Cancer Immunotherapy has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Loncar Cancer is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Vanguard Small and Loncar Cancer

The main advantage of trading using opposite Vanguard Small and Loncar Cancer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanguard Small position performs unexpectedly, Loncar Cancer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Loncar Cancer will offset losses from the drop in Loncar Cancer's long position.

The idea behind Vanguard Small Cap Index and Loncar Cancer Immunotherapy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.